152 related articles for article (PubMed ID: 2186841)
21. Megestrol acetate and minidose estrogen in prostatic carcinoma.
Geller J
Urology; 1988 Sep; 32(3):281-3. PubMed ID: 3413920
[No Abstract] [Full Text] [Related]
22. Newer methods of hormonal therapy for prostate cancer.
Soloway MS
Urology; 1984 Nov; 24(5 Suppl):30-8. PubMed ID: 6437034
[TBL] [Abstract][Full Text] [Related]
23. Antiandrogenic drugs.
McLeod DG
Cancer; 1993 Feb; 71(3 Suppl):1046-9. PubMed ID: 8428326
[TBL] [Abstract][Full Text] [Related]
24. Ketoconazole therapy for hormonally refractive metastatic prostate cancer.
Johnson DE; Babaian RJ; von Eschenbach AC; Wishnow KI; Tenney D
Urology; 1988 Feb; 31(2):132-4. PubMed ID: 3341098
[TBL] [Abstract][Full Text] [Related]
25. Managing hot flashes in men being treated for prostate cancer.
Baum NH; Torti DC
Geriatrics; 2007 Nov; 62(11):18-21. PubMed ID: 17999566
[TBL] [Abstract][Full Text] [Related]
26. Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome.
Dawson NA; McLeod DG
J Urol; 1995 Jun; 153(6):1946-7. PubMed ID: 7538601
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Megace, Stilphostrol, Megace plus DES, or streptozotocin in metastatic prostatic cancer in patients with hormonal failure and prior radiotherapy.
McLeod DG; Murphy GP; Priore R
Urology; 1988 Nov; 32(5):431-6. PubMed ID: 2973171
[TBL] [Abstract][Full Text] [Related]
28. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
[TBL] [Abstract][Full Text] [Related]
29. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL
Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393
[TBL] [Abstract][Full Text] [Related]
30. [Recurrence of cancer of the prostate after initial treatment with diethylstilbestrol (DES) in a homogeneous series of 175 cases].
Reziciner S
Ann Urol (Paris); 1997; 31(4):213-24. PubMed ID: 9412346
[TBL] [Abstract][Full Text] [Related]
31. Treatment of prostatic cancer. Newer forms of androgen deprivation.
Soloway MS
Postgrad Med; 1986 Jul; 80(1):249-52, 257-8. PubMed ID: 2941729
[TBL] [Abstract][Full Text] [Related]
32. Medical castration of males with megestrol acetate and small doses of diethylstilbestrol.
Geller J; Albert J; Yen SS; Geller S; Loza D
J Clin Endocrinol Metab; 1981 Mar; 52(3):576-80. PubMed ID: 6161942
[TBL] [Abstract][Full Text] [Related]
33. Treatment of stage D prostatic carcinoma with megestrol acetate.
Block M; Bonomi P; Anderson K; Wolter J; Showel J; Pessis D; Slayton R
J Surg Oncol; 1981; 17(4):367-71. PubMed ID: 7265976
[TBL] [Abstract][Full Text] [Related]
34. Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07.
Pilepich MV; Krall JM; John MJ; Rubin P; Porter AT; Marcial VA; Martz KL
Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):813-7. PubMed ID: 2646266
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83-07.
Pilepich MV; Buzydlowski JW; John MJ; Rubin P; McGowan DG; Marcial VA
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):175-80. PubMed ID: 7721614
[TBL] [Abstract][Full Text] [Related]
36. Megestrol acetate for the palliation of advanced ovarian carcinoma.
Geisler HE
Obstet Gynecol; 1983 Jan; 61(1):95-8. PubMed ID: 6185891
[TBL] [Abstract][Full Text] [Related]
37. Treatment of advanced prostatic cancer.
Sogani PC; Fair WR
Urol Clin North Am; 1987 May; 14(2):353-71. PubMed ID: 2953100
[TBL] [Abstract][Full Text] [Related]
38. Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment.
Blackledge GR; Latief T; Mould JJ; Spooner D; Morrison M
Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1091-4. PubMed ID: 2946584
[TBL] [Abstract][Full Text] [Related]
39. Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.
Pronzato P; Brema F; Amoroso D; Bertelli G; Conte PF; Martini MC; Pastorino G; Rosso R
Breast Cancer Res Treat; 1990 Nov; 17(1):51-4. PubMed ID: 2095927
[TBL] [Abstract][Full Text] [Related]
40. Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
Bollack C; Rougeron G
Am J Clin Oncol; 1988; 11 Suppl 2():S156-9. PubMed ID: 2977270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
